Drug Recall Enforcement Report Class I voluntary initiated by MERCK SHARP & DOHME CORP, originally initiated on 10-19-2021 for the product Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01 The product was recalled due to presence of particulate matter: identified as glass particles. The product was distributed nationwide and the recall is currently ongoing.